Willingness to Wait For a Vaccine Against COVID-19: Results of a Preference Survey

Overview

Journal Patient

Specialty Health Services

Date 2020 Dec 14

PMID 33313991

Citations 8

Authors

Tommi Tervonen

Aura Cecilia Jimenez-Moreno

Nicolas Krucien

Heather Gelhorn

Kevin Marsh

Sebastian Heidenreich

Affiliations

Soon will be listed here.

Citing Articles

The path towards herd immunity: Predicting COVID-19 vaccination uptake through results from a stated choice study across six continents.

Hess S, Lancsar E, Mariel P, Meyerhoff J, Song F, van den Broek-Altenburg E Soc Sci Med. 2022; 298:114800.

PMID: 35287066 PMC: 8848547. DOI: 10.1016/j.socscimed.2022.114800.

Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics.

Muhlbacher A, Sadler A, Jordan Y Eur J Health Econ. 2022; 23(9):1483-1496.

PMID: 35138495 PMC: 9468277. DOI: 10.1007/s10198-022-01438-w.

Public Preferences for a COVID-19 Vaccination Program in Quebec: A Discrete Choice Experiment.

Morillon G, Poder T Pharmacoeconomics. 2022; 40(3):341-354.

PMID: 35048317 PMC: 8769946. DOI: 10.1007/s40273-021-01124-4.

"Please, you go first!" preferences for a COVID-19 vaccine among adults in the Netherlands.

Mouter N, de Ruijter A, de Wit G, Lambooij M, Van Wijhe M, van Exel J Soc Sci Med. 2021; 292:114626.

PMID: 34883311 PMC: 8636308. DOI: 10.1016/j.socscimed.2021.114626.

Parents' willingness and attitudes concerning the COVID-19 vaccine: A cross-sectional study.

Yilmaz M, Sahin M Int J Clin Pract. 2021; 75(9):e14364.

PMID: 33998108 PMC: 8236907. DOI: 10.1111/ijcp.14364.

References

Bartsch S, Ferguson M, McKinnell J, OShea K, Wedlock P, Siegmund S . The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States. Health Aff (Millwood). 2020; 39(6):927-935. PMC: 11027994. DOI: 10.1377/hlthaff.2020.00426. View

Giannakeas V, Bhatia D, Warkentin M, Bogoch I, Stall N . Estimating the Maximum Capacity of COVID-19 Cases Manageable per Day Given a Health Care System's Constrained Resources. Ann Intern Med. 2020; 173(5):407-410. PMC: 7179996. DOI: 10.7326/M20-1169. View

The Lancet . COVID-19: fighting panic with information. Lancet. 2020; 395(10224):537. PMC: 7138040. DOI: 10.1016/S0140-6736(20)30379-2. View

Hellewell J, Abbott S, Gimma A, Bosse N, Jarvis C, Russell T . Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020; 8(4):e488-e496. PMC: 7097845. DOI: 10.1016/S2214-109X(20)30074-7. View

Anderson R, Heesterbeek H, Klinkenberg D, Hollingsworth T . How will country-based mitigation measures influence the course of the COVID-19 epidemic?. Lancet. 2020; 395(10228):931-934. PMC: 7158572. DOI: 10.1016/S0140-6736(20)30567-5. View

Trogen B, Oshinsky D, Caplan A . Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust. JAMA. 2020; 323(24):2460-2461. DOI: 10.1001/jama.2020.8917. View

Grasselli G, Pesenti A, Cecconi M . Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020; 323(16):1545-1546. DOI: 10.1001/jama.2020.4031. View

Armitage R, Nellums L . COVID-19 and the consequences of isolating the elderly. Lancet Public Health. 2020; 5(5):e256. PMC: 7104160. DOI: 10.1016/S2468-2667(20)30061-X. View

Sanders J, Monogue M, Jodlowski T, Cutrell J . Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 323(18):1824-1836. DOI: 10.1001/jama.2020.6019. View

10.

Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q . Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China. JAMA. 2020; 323(19):1915-1923. PMC: 7149375. DOI: 10.1001/jama.2020.6130. View

11.

Imai N, Gaythorpe K, Abbott S, Bhatia S, van Elsland S, Prem K . Adoption and impact of non-pharmaceutical interventions for COVID-19. Wellcome Open Res. 2020; 5:59. PMC: 7255913. DOI: 10.12688/wellcomeopenres.15808.1. View

12.

Koo J, Cook A, Park M, Sun Y, Sun H, Lim J . Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis. 2020; 20(6):678-688. PMC: 7158571. DOI: 10.1016/S1473-3099(20)30162-6. View

13.

Lurie N, Saville M, Hatchett R, Halton J . Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med. 2020; 382(21):1969-1973. DOI: 10.1056/NEJMp2005630. View

14.

Ueda M, Martins R, Hendrie P, McDonnell T, Crews J, Wong T . Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal. J Natl Compr Canc Netw. 2020; :1-4. DOI: 10.6004/jnccn.2020.7560. View

15.

Shoukat A, Wells C, Langley J, Singer B, Galvani A, Moghadas S . Projecting demand for critical care beds during COVID-19 outbreaks in Canada. CMAJ. 2020; 192(19):E489-E496. PMC: 7234264. DOI: 10.1503/cmaj.200457. View

16.

Le T, Andreadakis Z, Kumar A, Roman R, Tollefsen S, Saville M . The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020; 19(5):305-306. DOI: 10.1038/d41573-020-00073-5. View

17.

Sohrabi C, Alsafi Z, ONeill N, Khan M, Kerwan A, Al-Jabir A . World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020; 76:71-76. PMC: 7105032. DOI: 10.1016/j.ijsu.2020.02.034. View

18.

. Global coalition to accelerate COVID-19 clinical research in resource-limited settings. Lancet. 2020; 395(10233):1322-1325. PMC: 7270833. DOI: 10.1016/S0140-6736(20)30798-4. View

19.

Hotez P, Corry D, Bottazzi M . COVID-19 vaccine design: the Janus face of immune enhancement. Nat Rev Immunol. 2020; 20(6):347-348. PMC: 7187801. DOI: 10.1038/s41577-020-0323-4. View

20.

Abrams E, Szefler S . COVID-19 and the impact of social determinants of health. Lancet Respir Med. 2020; 8(7):659-661. PMC: 7234789. DOI: 10.1016/S2213-2600(20)30234-4. View